On 28 January 2021, SAHPRA implemented a controlled compassionate use programme under Section 21 of the Medicines and Related Substances Control Act, relating to the prescribing of Ivermectin in the management of COVID-19.
If you are intending to prescribe Ivermectin – pursuant to a Section 21 authorisation – and want to be able to request assistance from Medical Protection for matters arising from the prescribing of Ivermectin, you must supply the following information to us within 7 days of receiving SAHPRA approval: